Posts in tag

medicines australia


Medicines Australia says it is concerned about “increasingly alarmist and misguided” reporting by some media on negotiations for the Trans Pacific Partnership (TPP) and its impacts on the prices for …

Medicines Australia has launched an awareness campaign to ensure healthcare professionals are aware of and understand the effects of new transparency enhancements contained in its updated Code of Conduct. From …

Medicines Australia has welcomed the recommendations of an independent review into the TGA which, if adopted, will help to cut time delays and improve Australian’s access to innovative new medicines, …

Medicines Australia says it is “extremely disappointed” with a last-minute decision by Health Minister Sussan Ley to abandon a Strategic Agreement, which it says casts a shadow over the future …

The Grattan Institute’s latest report misses the point on medicines pricing, says Medicines Australia. Enduring reforms to the PBS polices are achieving substantial savings for government and the Australian medicines …

Medicines Australia has agreed to sign a ‘Letter of Intent’ with the Australian Government for a five-year strategic agreement. If finalised, the agreement will provide Australian patients and the medicines …

Medicines Australia has launched a consumer campaign urging the public to lobby their local MPs to safeguard the PBS and prevent further cuts. Its new campaign features a consumer website …

Australia’s innovative medicines industry has called on the Abbott Government to negotiate a five-year strategic agreement after it reached an in-principle deal with the Pharmacy Guild of Australia. Medicines Australia …

Australia’s peak medicines body has called on the Federal Government to clarify the extent of Budget cuts likely to affect essential and life-saving pharmaceuticals. Medicines Australia says it remains concerned …

Medicines Australia has expressed concerns about the proposed cuts to the PBS in tomorrow’s Budget. Health Minister, Sussan Ley’s announcement of the listing of new medicines and vaccines on the …

The Australian Competition and Consumer Commission is requiring Medicines Australia to strengthen its public reporting as a part of authorising edition 18 of its Code of Conduct for five years. …

Medicines Australia and medicines industry representatives have appeared before the Senate Inquiry into the availability of new, innovative and specialist cancer drugs in Australia, calling for improvements to create an …